An oncolytic vaccinia virus encoding anti-CD47 nanobody reshapes the tumor microenvironment to enhance cancer chemotherapy and immunotherapy in multiple myeloma
This study developed an oncolytic vaccinia virus encoding an anti CD47 nanobody named OVV aCD47nb to address the immunosuppressive tumor microenvironment and therapy resistance in multiple myeloma